(Q50970015)

26 March 2018

title

Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients. (English)

1 reference

26 March 2018

1 reference

2

1 reference

26 March 2018

author name string

M H Alderman

series ordinal

1

1 reference

26 March 2018

R Roqué

series ordinal

3

1 reference

26 March 2018

S Madhavan

series ordinal

4

1 reference

26 March 2018

language of work or name

English

0 references

publication date

1 March 1997

1 reference

26 March 2018

published in

The Lancet

1 reference

26 March 2018

volume

349

1 reference

26 March 2018

issue

9052

1 reference

26 March 2018

page(s)

594-598

1 reference

26 March 2018

The risk of myocardial infarction associated with antihypertensive drug therapies

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2908359-6

7 January 2021

Long-term survival and use of antihypertensive medications in older persons

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2908359-6

7 January 2021

Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2908359-6

7 January 2021

Do calcium channel blockers increase the risk of cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2908359-6

7 January 2021

Detection and Treatment of Hypertension at the Work Site

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2908359-6

7 January 2021

Hypertension control at the work site

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2908359-6

7 January 2021

Antihypertensive Drug Therapy. The effect of JNC criteria on prescribing patterns and patient status through the first year.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2908359-6

7 January 2021

Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2908359-6

7 January 2021

Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2908359-6

7 January 2021

10.1016/S0140-6736(96)08359-6

Identifiers

DOI

1 reference

26 March 2018

release_ougpco5conb5nolqslp2pldyvm

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ougpco5conb5nolqslp2pldyvm

24 November 2022

mapped directly with Wikidata item

PubMed ID

9057730

1 reference

26 March 2018